% | $
Quotes you view appear here for quick access.

Biogen Inc. Message Board

  • herenser herenser Nov 27, 2009 11:34 AM Flag

    New MS Treatment

    Should I sell my BIIB shares? If this treatment is widely acceptable, Biogen may be in big trouble.
    It is called "Liberation Treatment". According to this MS is a vascular problem.

    Also look for Prof.Dr.Zamboni, CCSVI. It looks like it is getting huge interest from the people with MS.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You better sell your stocks. Their drugs are only prolonging this disease. They know this and realize they can keep the billion dollar industry in the black as long as we keep paying. Greed has its own rewards.
      Liberation puts them out of business. That is why Biogen, among others, are placing so many obstacles in our way. Our own NMSS is doing nothing. You think the nmss wants to find a cure? No way, they would lose their $209 million dollar budget if we don't need them anymore. Where is the fastrack studies they promised? Non-existent is where.

    • Sell that BIIB stock!!!!

      No more drugs for MS! Liberation is now available around the world!

      Biogen will be in real trouble because of the Liberation Treatment!

      More & more people are being liberated around the world!

    • yes, the risk is so low on this procedure. a lot less than all the drugs they are trying to push on us!

      this procedure and testing is available elsewhere, but not here in the U.S.-why is that? big pharma.

      People want this available NOW. not later when we have progressed so much that nothing will help.

    • Over 1000 Canadians and Americans have received the Liberation treatment so far since November 2009. Every day more and more clinics open up around the world. Dr's are treat approx. 5 patients per day per clinic! I was treated on March 30. I have stopped taking my MS meds and know many folks who have stopped or plan to stop post liberation. Kuwait is treating all it's MS patients for CCSVI and Australia does it also. Scotland will start in July. Poland, Bulgaria, Germany, Mexico, Costa Rica! All these countries are treating for CCSVI because the demand is intense! I would start dumping my pharma stck now if I were you.

    • Just to let you see into the mindset of an MS patient. I'm a capatalist with MS and I do think that the industry has treated this a bit like described. Don't cure; treat. Here's a link so you can see what goes through our minds when we read about this new "study" (a laugh).

    • You must have read the Wall St. Journal article. Her parents even tried to clear that up. Yes the coumadin aided the bleeding, but look up hemmorhagic stroke and see the mortality rate. And I got news for you. About 95% of MS patients would take the risk mortality rate be damned. The choices we have suck and that's the bottom line. The drugs are ineffective at best and detrimental at worst.

      Read this. I know the competition to make money is what this board is about and that is what it is. However, I'm just trying to give an actual person who'se used the drugs' perspective. All I'm saying is keep a close eye because even if this all goes up in smoke, people with MS will keep pursuing other things because these drugs simply don't do a very good job.

    • This is true. I knew the patient that died on the way home and her family and the med. investigators proved that it was a hemmorhagic stroke unrelated to the procedure. The blood thinners she was on, however, made the stroke almost certainly fatal. But hemmorhagic strokes are fatal about 80% of the time anyway.

      There are places performing the procedure right now even though Stanford stopped. Kings County in New York, Georgetown University in DC (look up the AP article about this) and a hospital, the name escapes me, in Albany, NY.

      It's also going on in India, Poland and other places as well. That Stanford article in the WSJ was written by a guy that was going to write on the Georgetown piece, but the AP broke it first. He had a little sour grapes and that's why the article is so negatively slanted to appear like it's been "shut down". Only Stanford stopped, but it's gaining steam all over the world and the NMSS (National MS Society) is starting to provide funding for studies.

      Whether this takes the place of drug therapies or not remains unclear, but I can almost guarantee it will become part of the puzzle.

      The AP story was by a Lauran Neergaard and the title in the Dayton Daily News was "patients excited about new MS theory". I believe it was in USA Today as well. All I know is that it was in 600 some publications the other day.

      The only other thing I can add is only my own testimonial. I stopped Tysabri after having this procedure done and I'm far better off than I was on the Tysabri; I was still progressing pretty rapidly on that stuff.

    • MS Program Halted Amid Controversy
      After Patients Push for Experimental Treatment, Doctors Conclude It's Too Risky!

      In December, Dr. Dake's 40-patient MS stenting program was shut down, according to Stanford officials. A number of patients treated by Dr. Dake had reported improvements in their symptoms following the procedure. However, one patient died of a brain hemorrhage on the way home from treatment and another had to undergo life-saving emergency surgery. Neurologists from Stanford and the University of California, San Francisco, had protested to Stanford medical school officials that the procedure was too untested to be used in people. It's not clear which factors contributed to the program's ending.

    • Your words reflect your wishful thinking.
      Many have been operated already in Stanford. Newer clinics have started offering treatment. I have no doubt that US will have sufficient clinics offering this treatment in next 1 year. Even otherwise India, Poland ... would be happy to oblige ...

      I don't think other countries will wait until for US to complete 10 year study on this method ...

    • go ahead, I am willing to correct myself ...
      The fact is MS being an autoimmune disease (which is one of the basic assumption in your post) does not hold water. More facts for your consumption ...

      For quite sometime there have been two school of thought. One that believed that it is an autoimmune disease and other that believed that it is due to blood flow and vascular. A researcher went upto the extent of proving this in animal but could not take it beyond that as imaging and surgical technology was in adequate and was critical to prove the theory. Then came autoimmune theory and gave much needed relief and was embraced. So CCSVI is not new. It is just that it was always in the back burner. The point is that immune treatment for MS have gone past their shelf life and will have to give way to CCSVI.

    • View More Messages
290.78+0.13(+0.04%)Oct 24 4:00 PMEDT